Skip to main content

Table 1 Clinical and echocardiographic groups’ baseline characteristics

From: The impact of pericardial approach and myocardial protection onto postoperative right ventricle function reduction

  Group 1 (n = 17) Group 2
(n = 10)
Group 3 (n = 17) P value
Age, y 54.8 ± 11.9 59.2 ± 10.2 50.9 ± 12.2 0.14
Male, n (%) 13 (76%) 7 (70%) 14 (82%) 0.18
BSA (m2) 1.9 ± 0.2 1.8 ± 0.2 1.8 ± 0.1 0.32
EuroSCORE 2* 0.98% 0.96% 0.95% 0.45
LVEF 60.4 ± 6.4 58.2 ± 4.1 64.5 ± 4.7 0.32
TAPSE (mm) 24.5 ± 4.8 27.4 ± 5.3 23.5 ± 4 0.17
SPAP (mmHg) 33.9 ± 4.8 32.3 ± 5.1 34.9 ± 2.7 0.83
RVEF (3D) 62.2 ± 8.9 60.5 ± 8.2 58.5 ± 6.1 0.56
RVSV (3D) 68.3 ± 23.9 54.1 ± 18.8 68 ± 13.1 0.21
RVESV (3D) 43.4 ± 22.5 34.7 ± 11.7 48.5 ± 11.6 0.34Ɨ
RVEDV (3D) 111.7 ± 42.8 88.8 ± 26.1 116.5 ± 19.8 0.18φ
MVP Type
 Posterior leaflet prolapse 17 9 17  
 Anterior leaflet prolapse 2 1 1  
  1. *EuroSCORE 2 denotes the European System for Cardiac Operative Risk Evaluation (2nd version)
  2. Ɨp = 0.04 Group 2 versus 3
  3. φp = 0.03 Group 2 versus 3
  4. BSA Indicates body surface area, LVEF Left ventricular ejection fraction, TAPSE Tricuspid annular plane systolic excursion, SPAP Systolic pulmonary arterial pressure, RVEF Right ventricular ejection fraction, RVSV Right ventricular stroke volume, RVESV Right ventricular end-systolic volume, RVEDV Right ventricular end-diastolic volume, MVP Mitral valve prolapse